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Abstract
Background: Several clinical practice guidelines (CPG) on antithrombotic prophylaxis in surgical
patients help to decide about the prophylaxis strategy based on the patient risk of deep venous
thrombosis (DVT). However, the physician risk estimates of DVT could have little inter-observer
reproducibility, which could lead to different individual prophylaxis practices.
Methods: Physicians were asked to evaluate DVT risk in eight clinical vignettes, describing actual
patients cared for in our hospital. The vignettes included all possible levels of DVT risk.
Results: The degree of prophylaxis strategies accuracy was 63% (95% CI 523–75%). Overall
agreement was 0.32 (z = 7.61, p < 0.001) and for each level of risk kappa was 0.38 (z = 6.50, p <
0.001); 0.1 (z = 1.65, p < 0.049) and 0.5 (z = 8.45, p < 0.001) for small, moderate and high risk group
respectively
Conclusions: Our results showed that there is poor agreement when physicians have to evaluate
the risk for postoperative DVT, and in the cases of low and moderate risks of DVT there is the
smallest agreement. In addition, the data also showed that the overall accuracy of DVT prophylaxis
strategy was only moderate and the risk evaluation did not correlate to the selection of the
strategy. The issue of inter-observers variability should be taken into account when CPG
performance are analysed, especially when considering the risk-evaluation to choose the
appropriate actions.
Background
Deep venous thrombosis (DVT) prophylaxis is an effec-
tive intervention in the postoperative period  [1]. Several
clinical practice guidelines (CPG) on the topic have been
published, with the aim to increase the utilisation and ap-
propriateness of this practice. Usually, these guidelines es-
tablished the choice of the prophylaxis strategies based on
the type of surgery, as well as on the presence of specific
patient's risk factors [1,2]
To establish an individual patient risk level is a complex
task that could lead to substantial variations between ob-
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servers. The integration of several cognitive inputs and pa-
tient data under real work pressures is a task where the
physicians' performance is sub-optimal [3].
In order to determine if there are variations in the postop-
erative DVT risk perception among physicians, we per-
formed a study using clinical vignettes.
Methods
Study design
Clinical practice guideline
Our guideline on DVT prophylaxis is mostly based in the
5th ACCP consensus conference recommendation [1],
where risk-assessment approaches are used to decide the
prophylaxis strategy.
In our guideline, the postoperative DVT risk is evaluated
basing on the items that follow: the age, the presence of
venous thrombosis risk factors and the duration of sur-
gery. With this information we could classify the patients
in low, moderate and high-risk groups. Early mobilisation
or graded compression stockings are prescribed in the case
of low risk group patients. Moderate risk patients are pre-
scribed fixed subcutaneous calcium heparin and graded
compression stockings could replace heparin if high
haemorrhagic risk exists. High-risk patients received
nadroparin but when it was deemed inappropriate due to
a high haemorrhagic risk, intermittent pneumatic calf
compression (IPCC) was indicated. Both nadroparin and
IPCC may be used in selected high-risk patients. The
guideline has been widely publicized throughout the in-
stitution and it is available in the Hospital Intranet.
Clinical Vignettes
We have written eight comprehensive clinical vignettes in-
cluding patients that cover the entire risk spectrum in or-
der to evaluate the inter-observer variability about the risk
assessment,. The information was mostly taken from actu-
al patients cared for at our hospital. Specific details were
changed in order to respect patient confidentiality and to
avoid clueing physicians about the appropriate decisions.
The vignettes are summarised in the table. No consent is
required in our hospital to use clinical record data if no
breach to patient confidentiality is possible. One of us
(DG) independently reviewed the clinical vignettes for ac-
curacy and validation regarding the study objectives.
We randomly chose 10 physicians from the Internal Med-
icine and the Intensive Care Unit to read the vignettes.
Then we asked them: 1) to estimate the inhospital compli-
cations risks (nosocomial infection, cardio-respiratory
events, DVT risk and hospital mortality) and to classify
them in three levels: low, moderate and high risk; and 2)
to order a complete diagnostic and therapeutic plan for
each vignette.
Table 1: Clinical Vignettes summary with risk level and proposed prophylaxis strategyin the CPG.
Clinical Vignettes Summary Post-operative 
DVT risk
Prophylaxis Comment
Case 1: 31- years female post rhinoplasty, no past medical history, une-
ventful operation.
Small ED/GCS
Case 2: 25 years male insulin dependent diabetes after a correction of 
hallux valgus. Developed postoperative hyperglycemia.
Small EM/GCS*
Case 3: 63- years old female post hysterectomy with non-insulin 
dependent diabetes. After returning from the operating room a blood 
pressure of 225/130 was noted responding to analgesia.
High Nadroparin
Case 4: 42- years old obese male with chronic stable angina history. 
Resection of melanoma in the malar region.
Moderate Calcium 
Heparin
Case 5: 50- years old male with a 2-month history of macroscopic hema-
turia and pain in the right lumbar fossa. CT scan showed a right renal 
mass. He was neprhectomised
High Nadroparin IPCC** not indicated since hemor-
rhage source was controlled
Case 6: 88- years old female with a history of duodenal ulcer in her 
youth admitted due to hip fracture and operated 24 hs later. She was 
stable in the immediate postoperative period.
High Nadroparin
Case 7: 38- year old male with an upper gastrointestinal haemorrhage 
gastrectomised after failure of medical therapy. An ulcerated leiomioma 
was diagnosed.
Moderate Calcium 
heparin
IPCC could be acceptable
Case 8: 46 years-old obese male with hip septic arthritis and previous 
pulmonary embolism diagnosis. A resection of the femoral head was 
performed.
High Nadroparin 
+IPCC
*ED/GCS: Early mobilization or graded compression stockings. **IPCC: Intermittent pneumatic calf compression.BMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/16
Page 3 of 3
(page number not for citation purposes)
Statistical analysis
Percentages, along with 95% confidence intervals, were
calculated for the accuracy of the strategy selection com-
pared to the intended level of risk for the vignette, as de-
cided by the investigators.
The inter-observer agreement was evaluated using the ka-
ppa statistic for multiple raters and for multiple catego-
ries. Statistical calculations were performed with STATA
6.0.
Results
The degree of appropriateness of prophylaxis strategies
used were 63% (95% CI 52–75%).
There was no correlation found between the accuracy of
the prophylaxis strategies and the DVT risk evaluated by
the physician (χ 2 for trend 0.54, p = 0.46). Although no
statistically significant, the low risk strata showed a higher
rate of strategy inappropriate selection compared to the
moderate and high risk ones (72%, 61% and 61.5 respec-
tively, x2 = 0.7, p = 0.7). Overall agreement was 0.32 (z =
7.61, p < 0.001) and kappa by risk category was 0.38(z =
6.50, p < 0.001); 0.1(z = 1.65, p < 0.049) and 0.5 (z =
8.45, p < 0.001) for the low, moderate and high risk group
respectively.
All the DVT risk wrong estimates in the low risk group
were rated as "moderate" and in the moderate risk group
as "low risk". In the high-risk group, 70% of the wrong es-
timates were "low risk" and the rest were classified as
"moderate risk".
Discussion
Our results showed a poor agreement for assessing the risk
of postoperative DVT, especially in the low and moderate
risk groups. Wrongly classified patients who belong to
moderate risk groups were classified in lower risk catego-
ry. In addition, the data also showed that overall DVT
prophylaxis strategy was not good enough and the risk
evaluation did not correlate to the strategy selection.
As stated by Weed et al [3], our example on DVT risk as-
sessment showed that integration of cognitive inputs and
patient data must be systematically explored for different
clinical settings since considerable variation may occur,
especially when the physician behaviour is assessed.
The evaluation of the physician performance is a difficult
task, as several factors from physicians themselves, health-
care structure and case complexity could modify the eval-
uation. Clinical vignettes are a validated measurement of
the physician performance [4], as compared both to utili-
sation review and simulated patient-doctor encounters.
This method permits controlling case-mix, an important
confusing variable when the physician performance is
evaluated.
A standardised way of risk evaluation could improve the
quality of a key point in the decision process of the CPG,
such as risk assessment. Computerized decision support
systems have shown benefits in increasing usage and accu-
racy of DVT prophylaxis [5].
Conclusions
The issue of inter-observers variability should be taken
into account to analyse variations in CPG performance,
especially when considering risk-evaluation to select the
appropriate actions.
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